{"id":"https://openalex.org/W3097319475","doi":"https://doi.org/10.1183/13993003.congress-2020.984","title":"Exacerbation benefit by blood eosinophil counts with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial: a subgroup analysis","display_name":"Exacerbation benefit by blood eosinophil counts with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial: a subgroup analysis","publication_year":2020,"publication_date":"2020-09-07","ids":{"openalex":"https://openalex.org/W3097319475","doi":"https://doi.org/10.1183/13993003.congress-2020.984","mag":"3097319475"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2020.984","doi":"https://doi.org/10.1183/13993003.congress-2020.984","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2020.984","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028265360","display_name":"Klaus Friedrich Rabe","orcid":"https://orcid.org/0000-0002-7020-1401","observed_orcids":["https://orcid.org/0000-0002-7020-1401"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]},{"id":"https://openalex.org/I4210129183","display_name":"German Center for Lung Research","ror":"https://ror.org/03dx11k66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210129183","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus F. Rabe","raw_affiliation_strings":["LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany","institution_ids":["https://openalex.org/I32021983","https://openalex.org/I4210129183","https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100767595","display_name":"Fernando J. Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2412-3182","observed_orcids":["https://orcid.org/0000-0002-2412-3182","https://orcid.org/0000-0003-4957-8869","https://orcid.org/0000-0001-8298-2703"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando J. Martinez","raw_affiliation_strings":["Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070315113","display_name":"Gary T. Ferguson","orcid":"https://orcid.org/0000-0002-3277-4110","observed_orcids":["https://orcid.org/0000-0002-3277-4110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary T. Ferguson","raw_affiliation_strings":["Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100337500","display_name":"Chen Wang","orcid":"https://orcid.org/0000-0001-7857-5435","observed_orcids":["https://orcid.org/0000-0001-7857-5435","https://orcid.org/0000-0003-2638-3081"]},"institutions":[{"id":"https://openalex.org/I2801051648","display_name":"China-Japan Friendship Hospital","ror":"https://ror.org/037cjxp13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801051648"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Wang","raw_affiliation_strings":["National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China","institution_ids":["https://openalex.org/I2801051648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210092852","display_name":"Manchester University NHS Foundation Trust","ror":"https://ror.org/00he80998","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852"]},{"id":"https://openalex.org/I4210151016","display_name":"Medicines Evaluation Unit","ror":"https://ror.org/05e497m36","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210151016"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dave Singh","raw_affiliation_strings":["Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210092852","https://openalex.org/I4210151016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002250762","display_name":"Jadwiga Anna Wedzicha","orcid":"https://orcid.org/0000-0001-9642-1261","observed_orcids":["https://orcid.org/0000-0001-9642-1261","https://orcid.org/0000-0002-0910-4485"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jadwiga A. Wedzicha","raw_affiliation_strings":["National Heart and Lung Institute, Imperial College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart and Lung Institute, Imperial College London, London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020395774","display_name":"Roopa Trivedi","orcid":"https://orcid.org/0000-0001-5049-6313","observed_orcids":["https://orcid.org/0000-0001-5049-6313"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roopa Trivedi","raw_affiliation_strings":["AstraZeneca, Durham, NC, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Durham, NC, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101579066","display_name":"Earl St. Rose","orcid":"https://orcid.org/0000-0001-7269-437X","observed_orcids":["https://orcid.org/0000-0001-7269-437X"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Earl St Rose","raw_affiliation_strings":["AstraZeneca, Morristown, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Morristown, NJ, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039653551","display_name":"Shaila Ballal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaila Ballal","raw_affiliation_strings":["AstraZeneca, Morristown, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Morristown, NJ, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000615749","display_name":"Julie McLaren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Mclaren","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027975503","display_name":"Patrick F. Darken","orcid":"https://orcid.org/0000-0002-5608-2717","observed_orcids":["https://orcid.org/0000-0002-5608-2717"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Darken","raw_affiliation_strings":["AstraZeneca, Morristown, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Morristown, NJ, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081573795","display_name":"Magnus Aurivillius","orcid":"https://orcid.org/0000-0003-4660-5040","observed_orcids":["https://orcid.org/0000-0003-4660-5040"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Magnus Aurivillius","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077419098","display_name":"Colin Reisner","orcid":"https://orcid.org/0000-0003-1856-9863","observed_orcids":["https://orcid.org/0000-0003-1856-9863"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin Reisner","raw_affiliation_strings":["AstraZeneca, Morristown, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Morristown, NJ, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004903602","display_name":"Paul Dorinsky","orcid":"https://orcid.org/0000-0002-4814-0657","observed_orcids":["https://orcid.org/0000-0002-4814-0657"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Dorinsky","raw_affiliation_strings":["AstraZeneca, Durham, NC, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Durham, NC, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"984","last_page":"984"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.9120000004768372},{"id":"https://openalex.org/keywords/eosinophil-count","display_name":"eosinophil count","score":0.9539999961853027},{"id":"https://openalex.org/keywords/budesonide-glycopyrronium-formoterol","display_name":"budesonide/glycopyrronium/formoterol","score":0.9120000004768372},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.8830000162124634},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/step-up-therapy","display_name":"step-up therapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/laba-lama","display_name":"LAMA/LABA","score":0.6489999890327454},{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ethos-trial","display_name":"ETHOS trial","score":0.8349999785423279},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8696240186691284},{"id":"https://openalex.org/C2780667556","wikidata":"https://www.wikidata.org/wiki/Q16897784","display_name":"Metered-dose inhaler","level":4,"score":0.7945812940597534},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.7883606553077698},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.733683705329895},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.732820987701416},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.6144500374794006},{"id":"https://openalex.org/C2780911369","wikidata":"https://www.wikidata.org/wiki/Q753853","display_name":"Lama","level":3,"score":0.5110896229743958},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.503316342830658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39240801334381104},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.3293454051017761}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2020.984","doi":"https://doi.org/10.1183/13993003.congress-2020.984","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2020.984","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310713300","https://openalex.org/W3094817130","https://openalex.org/W3095863163","https://openalex.org/W2906315467","https://openalex.org/W3120617973","https://openalex.org/W3215289204","https://openalex.org/W4312479644","https://openalex.org/W3216299532","https://openalex.org/W2969213710","https://openalex.org/W4405336885"],"abstract_inverted_index":{"Background:":[0],"For":[1],"patients":[2,57,115,146,177],"who":[3],"experience":[4],"COPD":[5,46,71],"exacerbations":[6,47,129,155,169],"on":[7],"LAMA/LABA,":[8],"GOLD":[9],"recommends":[10],"step-up":[11,198],"to":[12,82,201],"ICS/LAMA/LABA":[13],"triple":[14,31,202],"therapy":[15,32],"for":[16,197],"those":[17],"with":[18,33,58,68,147,178],"blood":[19],"eosinophil":[20],"counts":[21],"(EOS)":[22],"\u2265100":[23,62,180],"cells/mm3.":[24],"In":[25,107,119,145],"the":[26,42,77,108],"52-week":[27],"ETHOS":[28],"trial":[29],"(NCT02465567),":[30],"BGF":[34,83,125,151,166],"MDI":[35,84,90,95,126,132,139,152,158,167,172,175,185],"at":[36],"two":[37],"ICS":[38],"dose":[39],"levels":[40],"reduced":[41,127,154,168],"rate":[43],"of":[44,114,124],"moderate/severe":[45,74,128],"vs":[48,130,156,162,170,183],"dual":[49],"therapies.":[50],"Objective:":[51],"To":[52],"assess":[53],"exacerbation":[54,75],"rates":[55],"in":[56,64,76,101,176,186],"EOS":[59,117,148,179,187],"<100":[60],"and":[61,72,137,173],"cells/mm3":[63],"ETHOS.":[65],"Methods:":[66],"Patients":[67],"moderate-to-very":[69],"severe":[70],"\u22651":[73],"prior":[78],"year":[79],"were":[80],"randomised":[81],"320/14.4/10\u00b5g":[85],"or":[86,92],"160/14.4/10\u00b5g,":[87],"glycopyrronium/formoterol":[88],"(GFF)":[89],"14.4/10\u00b5g":[91],"budesonide/formoterol":[93],"(BFF)":[94],"320/10\u00b5g":[96],"(all":[97],"treatments":[98],"administered":[99],"twice-daily":[100],"a":[102,194],"single":[103],"Aerosphere":[104],"inhaler).":[105],"Results:":[106],"modified":[109],"ITT":[110],"population":[111],"(n=8509),":[112],"82.6%":[113],"had":[116],"\u2265100.":[118],"these":[120],"patients,":[121],"both":[122,135,142,150],"doses":[123,153],"GFF":[131,163,171],"(by":[133,140],"28\u201329%,":[134],"p<0.0001)":[136],"BFF":[138,157,174,184],"11\u201312%,":[141],"p<0.03;":[143],"Table).":[144],"<100,":[149,188],"(p<0.04)":[159],"but":[160,181],"not":[161],"MDI.":[164],"Conclusions:":[165],"only":[182],"suggesting":[189],"this":[190],"cut-off":[191],"may":[192],"be":[193],"useful":[195],"guide":[196],"from":[199],"LAMA/LABA":[200],"therapy.":[203]},"counts_by_year":[{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2020-11-09T00:00:00"}